Pittsburgh Allegheny

1-year-old boy dies after ingesting heroin-fentanyl mix in Sharpsburg home; no charges, arrests

Natasha Lindstrom
By Natasha Lindstrom
1 Min Read April 29, 2020 | 6 years Ago
Go Ad-Free today

A 1-year-old boy died in September after ingesting a mix of heroin and fentanyl at a Sharpsburg home, authorities said Wednesday.

Few details are available regarding the death of the boy, who was identified by the Allegheny County Medical Examiner’s Office as Latayvis Kane LeRoy Gervasoni.

Emergency dispatchers received a 911 call about an unresponsive toddler in the 1000 block of North Canal Street at about 3:20 a.m. on Sept. 4, Allegheny County Police said.

Medics rushed the 1-year-old child to UPMC Children’s Hospital of Pittsburgh, the medical examiner said, where he was pronounced dead shortly later.

“Through the course of the investigation, detectives suspected that the child may have ingested illegal narcotics,” Allegheny County Police said in a statement.

Officials have not released any information about who was in charge of caring for the child that morning.

As of Wednesday, the medical examiner deemed the boy’s manner of death to be “undetermined.” The cause of death is listed as mixed drug intoxication, including heroin and fentanyl.

No charges or arrests have been made in the case, and police continue to investigate.

Officials urged anyone with information about the incident to call the county police tipline at 833-255-8477 (833-ALL-TIPS). Callers can remain anonymous.

Share

Tags:

About the Writers

Push Notifications

Get news alerts first, right in your browser.

Enable Notifications

Content you may have missed

Enjoy TribLIVE, Uninterrupted.

Support our journalism and get an ad-free experience on all your devices.

  • TribLIVE AdFree Monthly

    • Unlimited ad-free articles
    • Pay just $4.99 for your first month
  • TribLIVE AdFree Annually BEST VALUE

    • Unlimited ad-free articles
    • Billed annually, $49.99 for the first year
    • Save 50% on your first year
Get Ad-Free Access Now View other subscription options